This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Truong, M.-J.
Right arrow Articles by Bahr, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Truong, M.-J.
Right arrow Articles by Bahr, G. M.

 Previous Article  |  Next Article 

Journal of Virology, August 1999, p. 7008-7013, Vol. 73, No. 8
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Interleukin-16 Inhibits Human Immunodeficiency Virus Type 1 Entry and Replication in Macrophages and in Dendritic Cells

Marie-Jose Truong, Edith C. A. Darcissac, Emmanuel Hermann, Joelle Dewulf, Andre Capron, and George M. Bahr*

Institut Pasteur de Lille, INSERM U167, 59019 Lille Cedex, France

Received 25 February 1999/Accepted 19 April 1999

Recombinant interleukin-16 (rIL-16) has been found to inhibit human immunodeficiency virus type 1 (HIV-1) replication in acutely or endogenously infected CD4+ T cells. However, the effect of rIL-16 on HIV-1 replication in antigen-presenting cells (APCs) is still unknown. We show here a potent HIV-suppressive activity of rIL-16 in acutely infected monocyte-derived macrophages and dendritic cells determined by the levels of viral RNA transcripts or of viral reverse transcriptase in culture supernatants. The observed effect was dependent on the presence of rIL-16 early after infection and could not be induced by a 24-h treatment of cells with the cytokine prior to infection. Using macrophage-tropic and dually tropic primary isolates, we also showed that the addition of rIL-16 to cell cultures only during the infection period was effective in blocking virus entry and reducing proviral DNA levels in APCs. However, the anti-HIV activity of rIL-16 could not be linked to the induction of virus-suppressive concentrations of beta -chemokines or to the inhibition of HIV-enhancing cytokines. These findings establish a critical role for rIL-16 in protecting APCs against HIV-1 infection and lend further support to its potential use in the treatment of HIV disease.

* Corresponding author. Mailing address: Institut Pasteur de Lille, INSERM U167, 1 rue du Professeur Calmette, 59019 Lille Cedex, France. Phone: 33-320877168. Fax: 33-320877292. E-mail: georges.bahr{at}pasteur-lille.fr.

Journal of Virology, August 1999, p. 7008-7013, Vol. 73, No. 8
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Schulbin, H., Bode, H., Stocker, H., Schmidt, W., Zippel, T., Loddenkemper, C., Engelmann, E., Epple, H.-J., Arasteh, K., Zeitz, M., and Reiner Ullrich for the Kompetenznetz HIV/AIDS, (2008). Cytokine Expression in the Colonic Mucosa of Human Immunodeficiency Virus-Infected Individuals before and during 9 Months of Antiretroviral Therapy. Antimicrob. Agents Chemother. 52: 3377-3384 [Abstract] [Full Text]  
  • Qi, J. C., Wang, J., Mandadi, S., Tanaka, K., Roufogalis, B. D., Madigan, M. C., Lai, K., Yan, F., Chong, B. H., Stevens, R. L., Krilis, S. A. (2006). Human and mouse mast cells use the tetraspanin CD9 as an alternate interleukin-16 receptor. Blood 107: 135-142 [Abstract] [Full Text]  
  • Huang, Y., Babiuk, L. A., van Drunen Littel-van den Hurk, S. (2005). Immunization with a bovine herpesvirus 1 glycoprotein B DNA vaccine induces cytotoxic T-lymphocyte responses in mice and cattle. J. Gen. Virol. 86: 887-898 [Abstract] [Full Text]  
  • Cocude, C., Truong, M.-J., Billaut-Mulot, O., Delsart, V., Darcissac, E., Capron, A., Mouton, Y., Bahr, G. M. (2003). A novel cellular RNA helicase, RH116, differentially regulates cell growth, programmed cell death and human immunodeficiency virus type 1 replication. J. Gen. Virol. 84: 3215-3225 [Abstract] [Full Text]  
  • Archin, N. M., van den Boom, L., Perelygina, L., Hilliard, J. M., Atherton, S. S. (2003). Delayed Spread and Reduction in Virus Titer after Anterior Chamber Inoculation of a Recombinant of HSV-1 Expressing IL-16. IOVS 44: 3066-3076 [Abstract] [Full Text]  
  • Clapham, P. R., McKnight, A. (2002). Cell surface receptors, virus entry and tropism of primate lentiviruses. J. Gen. Virol. 83: 1809-1829 [Abstract] [Full Text]  
  • Tomiyama, H., Akari, H., Adachi, A., Takiguchi, M. (2002). Different Effects of Nef-Mediated HLA Class I Down-Regulation on Human Immunodeficiency Virus Type 1-Specific CD8+ T-Cell Cytolytic Activity and Cytokine Production. J. Virol. 76: 7535-7543 [Abstract] [Full Text]  
  • Qi, J. C., Stevens, R. L., Wadley, R., Collins, A., Cooley, M., Naif, H. M., Nasr, N., Cunningham, A., Katsoulotos, G., Wanigasek, Y., Roufogalis, B., Krilis, S. A. (2002). IL-16 Regulation of Human Mast Cells/Basophils and Their Susceptibility to HIV-1. J. Immunol. 168: 4127-4134 [Abstract] [Full Text]  
  • Darcissac, E. C. A., Truong, M.-J., Dewulf, J., Mouton, Y., Capron, A., Bahr, G. M. (2000). The Synthetic Immunomodulator Murabutide Controls Human Immunodeficiency Virus Type 1 Replication at Multiple Levels in Macrophages and Dendritic Cells. J. Virol. 74: 7794-7802 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»